- Abstract:
-
Many anticancer therapies, including ionizing radiation (IR), cause cytotoxicity through generation of DNA double-strand breaks (DSB). Delivery of therapeutic radionuclides to DNA DSB sites can amplify this DNA damage, for additional therapeutic gain. Herein, we report on two radiopharmaceuticals, radiolabeled with the Auger electron emitter (111)In, with dual specificity for both the intranuclear, DNA damage repair signaling protein γH2AX and the EGF receptor (EGFR). The EGFR ligand EGF was ...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- American Association for Cancer Research Publisher's website
- Journal:
- Molecular cancer therapeutics Journal website
- Volume:
- 12
- Issue:
- 11
- Pages:
- 2472-2482
- Publication date:
- 2013-11-05
- DOI:
- EISSN:
-
1538-8514
- ISSN:
-
1535-7163
- URN:
-
uuid:cdc2baa5-c9a3-443c-a446-c5b94a38aed7
- Source identifiers:
-
436127
- Local pid:
- pubs:436127
- Language:
- English
- Keywords:
- Copyright holder:
- American Association for Cancer Research
- Copyright date:
- 2013
Journal article
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
Actions
Authors
Funding
Cancer Research UK
More from this funder
CR-UK/EPSRC Cancer Imaging Centre
More from this funder
Oxford Experimental Cancer Medicine Centre
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record